Iradimed (NSDQ:IRMD) halted sales of its 3880 MRI-compatible vital signs monitor in the European Union, after its CE Mark approval expired last week. Winter Springs, Fla.-based Iradimed said the Jan. 17 expiration came after its notified body, UL International, reviewed its technical file and found that it ran afoul of new EU clinical evaluation rules. UL International […]
iRadimed (NSDQ:IRMD) said today that it won 510(k) clearance from the FDA for its 3880 MR-compatible patient monitoring system. The 3880 device is designed to allow patients to be transported from critical care units for magnetic resonance imaging scans without interruption to vital signs monitoring. Winter Springs, Fla.-based Iradimed claims it as the smallest and most-portable […]
Acelity said today it tapped R. Eckert as its new prez & CEO, succeeding Joseph Woody who is stepping away from Acelity following the company’s divestiture of its LifeCell division earlier this year. Eckert previously served as CEO of health information tech company TriZetto Corp, and has led 5 other companies including CRC Health Group, Eclipsys […]
Iradimed (NSDQ:IRMD) said it doesn’t need to perform any more human factors usability testing to get its bid for 510(k) clearance past the FDA for the MRidium 3860+ MRI-safe IV infusion pump. The FDA in September 2014 ordered Winter Springs, Fla.-based Iradimed to pursue a new 510(k) clearance for the 3860 version of the MRidium pump, citing […]
iRadimed launched its initial public offering today in hopes of raising $12.6 million for its non-magnetic infusion pumps.
The Florida-based device maker is offering just over 2 million shares at $6.25 apiece, as well as an additional 302,400 shares, worth about $1.9 million before underwriting discounts and commissions, to cover potential over-allotments.
iRadimed today set the range for its forthcoming initial public offering at $5 to $6 per share.
Winter Springs, Fla.-based iRadimed said it plans to issue 1.75 million shares in the IPO, making the offering worth between $8.75 million and $10.5 million.
Florida-based device maker iRadimed is looking to raise up to $12 million through an initial public offering, hoping to use the funds to expand its sales & marketing efforts and boost research & development for its MRI-friendly infusion pumps.
Florida-based infusion device company Iradimed landed in hot water with some units of its MRidium infusion pumps, the FDA giving the measure it’s highest-risk Class I recall status, a label reserved for the most serious device malfunctions that might result in death.